Topcon Corporation announces that following the successful completion of a management buyout (“MBO”), under which Topcon’s management team has acquired the Company, Topcon’s shares were delisted from the stock exchange as of December 2, 2025.
Strategic Partnership to Drive Long-Term Growth
Through this MBO, Topcon has formed a strong partnership with KKR Japan and JIC Capital, who have a deep understanding of its businesses and a strong alignment with Topcon’s corporate philosophy, to establish a more agile and flexible management structure. This will enable the company to accelerate strategic initiatives from a long-term perspective, including bold upfront investments, further strengthen Topcon’s competitiveness and drive the sustainable growth of its corporate value. Following the transition to a private company, the current management team will continue to lead and operate Topcon as before.
Topcon Healthcare (La Jolla, CA) will remain focused on executing its long-term strategy of Healthcare from the Eye with clarity and discipline advancing solutions that use the eye as a window to systemic health and enabling more connected, data-driven care at scale.
